Furthermore, the methylation status of a specific SORT1 promoter region, cg16988986, not only showed potential as a diagnostic marker to differentiate HCC tissues from non-tumor tissues but also exhibited a significant correlation with patient prognosis, indicating its utility as a prognostic biomarker. Here, SORT1 is linked to hepatocellular carcinoma.